2020
Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer
Jacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseHPV-negative oropharyngeal cancersChemoradiation therapyOverall survivalCancer DatabaseOropharyngeal cancerHPV-negative oropharyngeal squamous cell carcinomaLarge national cancer databaseNeck cancer-specific survivalOropharyngeal squamous cell carcinomaCox proportional hazards regressionKaplan-Meier survival analysisCancer-specific survivalImproved overall survivalMultivariable Cox regressionRetrospective cohort studyAdjuvant chemoradiation therapyUse of surgeryEnd Results ProgramProportional hazards regressionSquamous cell carcinomaSEER cohortAdjuvant therapyCohort studySEER database
2018
Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival
Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 519-525. PMID: 29801040, PMCID: PMC6583856, DOI: 10.1001/jamaoto.2018.0395.Peer-Reviewed Original ResearchConceptsHPV-positive statusHuman papillomavirus (HPV) statusOverall survivalHPV statusOral cavityHPV positivityRetrospective population-based cohort studyPopulation-based cohort studyCox multivariate regression modelNeck squamous cell carcinomaHPV-negative statusImproved overall survivalNational Cancer DatabaseHPV-negative tumorsHPV-positive tumorsIndependent prognostic factorHuman papillomavirus positivityUpper aerodigestive tractSquamous cell carcinomaLarge survival differencesCategory tumorsOropharynx subsiteCohort studyPrimary malignancyImproved survival
2015
Postmarket Modifications of High‐Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration
Rathi VK, Ross JS, Samuel AM, Mehra S. Postmarket Modifications of High‐Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration. Otolaryngology 2015, 153: 400-408. PMID: 26044785, DOI: 10.1177/0194599815587508.Peer-Reviewed Original ResearchConceptsClinical dataUS FoodDrug AdministrationPMA pathwayRetrospective cohort studyAdditional clinical dataPremarket approval pathwaySignificant clinical implicationsCohort studyHigh-risk medical devicesMedian numberClinical implicationsMarketing clearanceLife spanAdministrationSubstantial numberPMA applicationApproval pathwaySupplementsFDATherapeutic devicesPathway
2013
Factors Predictive of Voice and Swallowing Outcomes after Anterior Approaches to the Cervical Spine
Mehra S, Heineman TE, Cammisa FP, Girardi FP, Sama AA, Kutler DI. Factors Predictive of Voice and Swallowing Outcomes after Anterior Approaches to the Cervical Spine. Otolaryngology 2013, 150: 259-265. PMID: 24367048, DOI: 10.1177/0194599813515414.Peer-Reviewed Original ResearchConceptsAnterior transcervical approachSpinal levelAnterior approachSurgical factorsCervical spineTranscervical approachPostoperative voiceHistorical cohort studyKaplan-Meier methodVoice complaintsCervical spine diseaseAcademic medical centerSwallowing complaintsCohort studySwallowing outcomesConsecutive patientsMedian timePostoperative issuesSwallowing problemsFactors PredictiveSpine diseaseNeck surgeonsMedical CenterHigh incidencePatients
2011
Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer
Mehra S, Morris L, Shah J, Bilsky M, Selesnick S, Kraus D. Outcomes of Temporal Bone Resection for Locally Advanced Parotid Cancer. Journal Of Neurological Surgery Part B Skull Base 2011, 21: 389-396. PMID: 22547966, PMCID: PMC3312127, DOI: 10.1055/s-0031-1287682.Peer-Reviewed Original ResearchLateral temporal bone resectionRecurrence-free survivalAdvanced parotid cancerTemporal bone resectionParotid cancerLocoregional controlMost patientsDisease recurrenceBone resectionDisease-specific survival ratesActuarial locoregional controlBetter locoregional controlExtended radical parotidectomyRetrospective cohort studyAcceptable complication rateKaplan-Meier methodSurgical margin statusCox multivariate regressionGross total resectionLong-term survivalCohort studyComplication rateIndependent predictorsLocal recurrenceMargin status